Literature DB >> 22172093

Hemoptysis associated with leptospirosis acquired in Hawaii, USA.

Christopher A Duplessis, Marvin J Sklar, Ryan C Maves, Anne Spichler, Braden Hale, Mark Johnson, Mary Bavaro, Joseph M Vinetz.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22172093      PMCID: PMC3311216          DOI: 10.3201/eid1712.110700

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Severe pulmonary hemorrhagic syndrome (SPHS) is a serious complication of Leptospira infection, a globally widespread bacterial zoonosis that is increasing in incidence in tropical and subtropical regions. Despite decreasing endemicity of leptospirosis in industrialized regions, the disease is reemerging in travelers and recreationalists. Leptospirosis is an appreciable attributable cause of travel-related infections (typically associated with waterborne activities), and the incidence of travel-related leptospirosis is proportionally higher than that for endemic leptospirosis. Disease risk epidemiology has shifted concomitantly from occupational to recreational in industrialized countries (–). Risk factors include urbanization, climatic changes, and agricultural practices (–). Clinical features of leptospirosis range from asymptomatic infections and undifferentiated febrile syndromes to multiorgan dysfunction and death. Weil syndrome (i.e., severe leptospirosis) is characterized by renal and hepatic dysfunction, hyperbilirubinemia (disproportionate to transaminase elevation), and hemorrhage (pulmonary, gastrointestinal, or intracranial). Pulmonary involvement predicts poor clinical outcome: the case-fatality rate for persons with SPHS is >50% (–). Most US leptospirosis cases are reported from Hawaii, where the annual incidence is 1.63 cases/100,000 person-years (). Leptospirosis is endemic to Hawaii; however, SPHS is uncommonly reported (). We treated a 21-year-old active-duty Navy sailor for SPHS after he had a 5-day port visit in Hawaii, during which he went cliff-diving in Maunawili Falls. Afterwards, he returned to California and 2 days later sought medical attention in an outpatient clinic. Pharyngitis was diagnosed and azithromycin prescribed. Two days later, he was hospitalized with fever, chills, pharyngitis, dyspnea, nonproductive cough, headache, myalgias, hemoptysis, epistaxis, diarrhea, nausea, emesis, meningismus, and a lower-extremity rash. Vital signs included temperature 38.3°C, pulse 132 beats/min, blood pressure 128/72 mm Hg, and oxygen saturation 98% on room air. Physical examination noted conjunctival suffusion, epistaxis, posterior cervical and inguinal lymphadenopathy, bilaterally diminished breath sounds, rhonchi and crackles, bloody cough, tachycardia, hepatosplenomegaly, and a macular rash over the lower extremities. Laboratory studies were noteworthy for reference range leukocyte count, hemoglobin (11.8 g/dL), platelets (102 × 103/mm3), creatine phosphokinase (1,719 IU/L), sodium (128 mmol/L), bicarbonate (23 mmol/L), blood urea nitrogen (29 mg/dL), creatinine (2.2 mg/dL), aspartate aminotransferase (171 U/L), alanine aminotransferase (147 U/L), bilirubin (1.9 mg/dL), and urinalysis (7 erythrocytes and 9 leukocytes/high-power field). Chest radiography showed multilobar bilateral opacities, and cerebrospinal fluid (CSF) showed mild pleocytosis. The patient received intravenous acyclovir, ceftriaxone, and vancomycin and continued azithromycin. At hospital admission, the patient experienced respiratory decompensation requiring endotracheal intubation and mechanical ventilation. Results of blood, urine, and CSF cultures and CFS PCR (herpes simplex virus and enterovirus) remained negative at 48 hours, prompting discontinuation of vancomycin and acyclovir. Serologic test results for HIV, dengue fever virus, mycoplasma, and Chlamydophila and Rickettsia species were negative. Nasopharyngeal influenza PCR, Streptococcus pneumoniae and Legionella spp. urinary antigen test results and hepatitis panel results were negative. Leptospira spp. test results by culture, PCR, and serologic testing (ELISA and microscopic agglutination testing) were negative. Given an elevated suspicion for leptospirosis, ceftriaxone and azithromycin were continued through hospital day 7. The patient rapidly improved, was extubated after 48 hours, and was discharged on hospital day 7 with a 7-day course of oral doxycycline. A convalescent-phase serum sample had a titer of 1,600 against L. interrogans serovar Copenhageni, as determined by microscopic agglutination testing. SPHS is associated with infection with L. interrogans serovars Copenhageni and Icterohaemorrhagiae (), and the syndrome has been identified in diverse settings, including the Andaman Islands. Recent outbreaks have occurred in Nicaragua and Brazil (,). SPHS pathogenesis remains poorly understood. In animal models and human autopsy studies, immunoglobulin and complement are deposited along alveolar septa without a clear cause-and-effect relationship (). Bacterial virulence factors are postulated but unproven. Leptospires induce endothelial activation and pulmonary endothelial and epithelial injury (possibly by immune-complex deposition and/or autoimmune mechanisms) (). Pulmonary histopathology demonstrates a paucity of leptospires, and antigen levels do not correlate with injury severity (). Steroids, intravenous immunoglobulin, and plasma exchange are of unproven benefit but have been reported to be useful (). Genetically determined responses include associations with human leukocyte antigen–DQ6 and hyperactive Toll-like receptor 4–dependent immunity. Diagnosis of leptospirosis may have been delayed for this patient because of early empiric azithromycin administration. Azithromycin is increasingly recognized as a potentially effective treatment that is comparable or superior to doxycycline () and thus warrants testing in human trials. Given the paucity of SPHS in leptospirosis case reports from Hawaii, potential sentinel cases may be harbingers of more virulent disease expression. A potential parallel is the emergence of SPHS in Salvador, Brazil, in 2003. No cases were identified before 2003, but 47 cases and a 75% case-fatality rate were identified during 2003–2005 (,). The entrenched active surveillance and physician awareness of SPHS in neighboring Brazilian cities suggests it is unlikely that this observation stemmed from prior underrecognition of disease; instead, it suggests de novo emergence. Clinicians should consider leptospirosis (SPHS) in patients with acute fever accompanied by hemoptysis after travel to Hawaii, and leptospirosis should be suspected in any traveler with undifferentiated febrile illness, especially those reporting water exposures (). Vigilant national surveillance is needed to determine further emergence of SPHS in Hawaii.
  9 in total

Review 1.  Pathology and pathophysiology of pulmonary manifestations in leptospirosis.

Authors:  Marisa Dolhnikoff; Thais Mauad; Eduardo P Bethlem; Carlos Roberto Ribeiro Carvalho
Journal:  Braz J Infect Dis       Date:  2007-02       Impact factor: 1.949

2.  Predictors of lethality in severe leptospirosis in urban Brazil.

Authors:  Anne S Spichler; Pedro J Vilaça; Daniel A Athanazio; Jose O M Albuquerque; Marcia Buzzar; Bronislawa Castro; Antonio Seguro; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

Review 3.  Leptospirosis: an emerging disease in travellers.

Authors:  Colleen Lau; Lee Smythe; Philip Weinstein
Journal:  Travel Med Infect Dis       Date:  2010-01-06       Impact factor: 6.211

4.  Travel-related leptospirosis in Israel: a nationwide study.

Authors:  Eyal Leshem; Gadi Segal; Ada Barnea; Shmuel Yitzhaki; Iris Ostfeld; Silvio Pitlik; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

5.  Weil's disease: an unusually fulminant presentation characterized by pulmonary hemorrhage and shock.

Authors:  A Spichler; M Moock; E G Chapola; J Vinetz
Journal:  Braz J Infect Dis       Date:  2005-11-01       Impact factor: 1.949

6.  Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden.

Authors:  Eddy R Segura; Christian A Ganoza; Kalina Campos; Jessica N Ricaldi; Sonia Torres; Hermann Silva; Manuel J Céspedes; Michael A Matthias; Mark A Swancutt; Renzo López Liñán; Eduardo Gotuzzo; Humberto Guerra; Robert H Gilman; Joseph M Vinetz
Journal:  Clin Infect Dis       Date:  2005-01-10       Impact factor: 9.079

7.  Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface.

Authors:  J Croda; A N D Neto; R A Brasil; C Pagliari; A C Nicodemo; M I S Duarte
Journal:  Clin Microbiol Infect       Date:  2009-09-23       Impact factor: 8.067

8.  Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus.

Authors:  Kriangsak Phimda; Siriwan Hoontrakul; Chuanpit Suttinont; Sompong Chareonwat; Kitti Losuwanaluk; Sunee Chueasuwanchai; Wirongrong Chierakul; Duangjai Suwancharoen; Saowaluk Silpasakorn; Watcharee Saisongkorh; Sharon J Peacock; Nicholas P J Day; Yupin Suputtamongkol
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

9.  Leptospirosis in Hawaii, USA, 1999-2008.

Authors:  Alan R Katz; Arlene E Buchholz; Kialani Hinson; Sarah Y Park; Paul V Effler
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

  9 in total
  4 in total

1.  Comparative analyses of transport proteins encoded within the genomes of Leptospira species.

Authors:  Bora Buyuktimkin; Milton H Saier
Journal:  Microb Pathog       Date:  2016-06-11       Impact factor: 3.738

2.  Comparative genomic analyses of transport proteins encoded within the genomes of Leptospira species.

Authors:  Bora Buyuktimkin; Milton H Saier
Journal:  Microb Pathog       Date:  2015-08-03       Impact factor: 3.738

Review 3.  Globalization of leptospirosis through travel and migration.

Authors:  Medhani Bandara; Mahesha Ananda; Kolitha Wickramage; Elisabeth Berger; Suneth Agampodi
Journal:  Global Health       Date:  2014-08-12       Impact factor: 4.185

Review 4.  A systematic review of human and animal leptospirosis in the Pacific Islands reveals pathogen and reservoir diversity.

Authors:  Vanina Guernier; Cyrille Goarant; Jackie Benschop; Colleen L Lau
Journal:  PLoS Negl Trop Dis       Date:  2018-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.